Literature DB >> 142126

Some observations on SMON from Bombay.

N H Wadia.   

Abstract

Nine patients in whom subacute myelo-opticoneuropathy (SMON) was diagnosed with varying degrees of confidence are discussed. The cases were discovered after a retrospective examination of our records for the period 1967-71, and a prospective search from March 1972 to date. Subacute myelopathy with predominant dysaesthesiae and greater involvement of the pyramidal tracts was seen more often than fully developed SMON. Subacute myelopathy was seen in six instances, opticomyelopathy in two and myeloneuropathy only once. Clioquinol could not be excluded as an aetiological agent. The difference in the reported prevalence of SMON between Japan and India is noted, and factors which may account for this difference are discussed. Problems related to the diagnosis of SMON outside Japan, and particularly in India, are stressed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 142126      PMCID: PMC492661          DOI: 10.1136/jnnp.40.3.268

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  S.M.O.N. in Singapore.

Authors:  C H Tay
Journal:  Lancet       Date:  1973-06-30       Impact factor: 79.321

2.  S.M.O.N.

Authors:  J D Spillane
Journal:  Lancet       Date:  1972-01-15       Impact factor: 79.321

3.  S.M.O.N.

Authors:  J D Spillane
Journal:  Lancet       Date:  1971-12-18       Impact factor: 79.321

4.  Subacute myelo-optic neuropathy in Australia.

Authors:  G Selby
Journal:  Lancet       Date:  1972-01-15       Impact factor: 79.321

5.  Myelopathy after clioquinol treatment.

Authors:  P O Osterman
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

6.  [Polyneuropathy following long-term use of clioquinol (Enterovioform)].

Authors:  J A van Beeck; J B Scholten
Journal:  Ned Tijdschr Geneeskd       Date:  1972-09-02

7.  Subacute myelo-optic neuropathy: a probable case in the United States.

Authors:  B H Kean
Journal:  JAMA       Date:  1972-04-10       Impact factor: 56.272

8.  [Possible neurotoxicity of oxyquinolines].

Authors:  H E Kaeser; R Wüthrich
Journal:  Dtsch Med Wochenschr       Date:  1970-08-14       Impact factor: 0.628

9.  Myeloneuropathy with abdominal disorders in Japan. A clinical study of 752 cases.

Authors:  I Sobue; K Ando; M Iida; T Takayanagi; Y Yamamura; Y Matsuoka
Journal:  Neurology       Date:  1971-02       Impact factor: 9.910

Review 10.  Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.

Authors:  T W Meade
Journal:  Br J Prev Soc Med       Date:  1975-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.